Brian J. Paul is an attorney in the Tampa office of Shutts & Bowen LLP, where he is a member of the Intellectual Property practice group.
Brian is also a registered patent attorney and is admitted to practice before the United States Patent and Trademark Office (“USPTO”). His practice focuses primarily on matters related to technology, patent and trademark prosecution, as well as intellectual property transactions and litigation. He also advises clients on matters related to due diligence, investigations, licensing, and unfair competition.
With a background in biomedical science, Brian’s representative technology experience includes medical devices, life sciences, mechanical arts, security systems, automotive technology, agricultural technology, and consumer products. He is experienced in prosecuting patent and trademark applications both in the U.S. and in foreign jurisdictions.
While in law school, Brian served as an advocate in his law school’s Veterans Law Institute and successfully argued a case before the Board of Veterans’ Appeals to award his client service-related disability compensation. He also served as a Technology Transfer Extern at the University of South Florida, conducting detailed licensing analysis to identify potential licensing opportunities for University-sponsored patents and copyrights.
- Stetson University College of Law, J.D., 2019
- Highest Grade Designation in Patent Law, Fall 2018
- Joseph J. Reiter Scholarship, Spring 2018
- Business Law Society, Secretary
- Student Bar Association, Social Chair
- Guardian ad Litem, Child Advocate
- University of South Florida, B.S., Biomedical Sciences, 2016
- U.S. Patent and Trademark Office
- U.S. District Court for the Southern District of Florida
News & Insights
News & Speaking Engagements
- Co-Author, “S. Department of the Treasury Issues Update to IP-related Transactions in Russia,” JD Supra (May 9, 2022)
- Author, “Senate Confirms Kathi Vidal as Next USPTO Director,” JD Supra (April 7, 2022)
- Co-Author, “Federal Circuit Clarifies the Nexus Requirement for Objective Indicia of Nonobviousness,” JD Supra (March 17, 2022).